WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000059539) METHOD AND MEANS FOR TREATING POST-POLIO SYNDROME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/059539    International Application No.:    PCT/SE2000/000619
Publication Date: 12.10.2000 International Filing Date: 30.03.2000
Chapter 2 Demand Filed:    27.10.2000    
IPC:
C07K 16/00 (2006.01)
Applicants: PHARMALINK BASLÄKEMEDEL AB [SE/SE]; Kanalvägen 18, S-194 61 Upplands Väsby (SE) (For All Designated States Except US).
GONZALEZ, Henrik [SE/SE]; (SE) (For US Only).
BORG, Kristian [SE/SE]; (SE) (For US Only)
Inventors: GONZALEZ, Henrik; (SE).
BORG, Kristian; (SE)
Agent: CONIMAR AB; Box 2086, S-141 02 Huddinge (SE)
Priority Data:
09/285,125 01.04.1999 US
Title (EN) METHOD AND MEANS FOR TREATING POST-POLIO SYNDROME
(FR) METHODE ET MOYEN DE TRAITEMENT DU SYNDROME DE POST-POLIOMYELITE
Abstract: front page image
(EN)A method for treating a patient suffering from Post-Polio Syndrome (PPS) comprises the intravenous, intramuscular or subcutaneous administration of a pharmacologically effective amount of an immunomodulating agent, in particular gamma-globulin. Also disclosed is the use of the immunomodulating agent for the manufacture of a corresponding medicament, and a pharmaceutical composition for treatment of PPS comprising gamma-globulin.
(FR)Une méthode de traitement d'un patient souffrant du syndrome de post-poliomyélite (SPP) consiste en l'administration par voie intraveineuse, intramusculaire ou sous-cutanée d'une dose pharmacologique efficace d'un agent immunomodulant, en particulier de la gamma-globuline. L'invention a également trait à l'utilisation de l'agent immunomodulant dans la production d'un médicament correspondant, et une composition pharmaceutique de traitement de SPP contenant de la gamma-globuline.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)